'What does success look like for growing life sciences companies; is it aligned with what industry needs?’

During this round-table discussion our speakers will share their thoughts on the key areas that company leaders need to get right in order to achieve success - above and beyond excellent science. This includes an evolving strategy, deliverable targets, establishing a safe and inclusive environment, engaging in mutually beneficially collaborations that can transform R&D, being open to and adopting new technologies and complying with new standards and regulations.  


After introductory keynotes, we will invite guests to contribute to a round-table discussion on whether a company's expectation of success meets that of the industry. 


08.30 - 09.00   Guest arrival and breakfast served

09.00 - 09.30   Introductions & keynotes from:

Introduction from Stuart Rose, CEO of OBN

Keynotes from:

  • Matthew Beard PhD, Senior Director External Innovation at Ipsen
  • Sarah Pollitt,  Independent Pharma & Healthcare Strategic Advisor
  • Joe Illingworth, Director & Co-Founder at DJS Antibodies

09.30 - 10.30    Round table discussion with all guests and speakers, facilitated by OBN

About OBN's C-Suite Events:

OBN's round table C-Suite Events are designed exclusively for senior C-Suite leaders (or equivalent) from life sciences organisations, whether R&D or those involved in providing critical support services to the industry.

The purpose of these events is to generate some interesting, useful, high-level and boundary pushing discussion and debate, that creates some practical thought-leadership output.

Please note that places are limited and will be offered on an approval only basis.


  • Matthew Beard (Senior Director,  External Innovation of Ipsen)

    Matthew Beard

    Senior Director, External Innovation of Ipsen

    view more
  • Sarah Pollitt (Pharma & Healthcare Strategic Advisor)

    Sarah Pollitt

    Pharma & Healthcare Strategic Advisor

    view more
  • Joe Illingworth (Director, Research and Co-founder of DJS Antibodies)

    Joe Illingworth

    Director, Research and Co-founder of DJS Antibodies

    Joe is the CSO and Co-Founder of DJS Antibodies. Joe loves working in a small and focussed team to solve problems creatively. He was a leader in the establishment of HEPTAD, the mAb discovery engine at the heart of DJS, and now oversees all R&D activities within the company. His work covers mAb discovery and screening through to preclinical development of lead drugs, and he works closely with industry-leading experts as well as managing several government funded projects.
    Joe holds a BSc in Biochemistry from Imperial College London and a PhD in antibody discovery and characterisation from the University of Oxford. After studying Joe worked as an academic on antibody induction and vaccination.
    In his spare time he loves playing the guitar, sailing, kicking a football around and growing vegetables.

    view more


OBN Member, Complimentary - C-Suite Only
Member Price Complimentary
OBN Non-Member - C-Suite Only
Standard Price £50


Ipsen UK

102 Park Dr, Milton, Abingdon OX14 4RZ
Abingdon, Oxfordshire, United Kingdom

If you have any questions please contact Jane Odriscoll

Contact Organizer

Show on map